Secondary Adult's Hemophagocytic Lymphohistiocytosis and Innate Immunity
Hemophagocytic Lymphohisticytosis
About this trial
This is an interventional basic science trial for Hemophagocytic Lymphohisticytosis
Eligibility Criteria
Inclusion Criteria:
Patients Hemophagocytic lymphohisticytosis group:
- Of more than 18 years old
- affected by secondary LH infections with the exception of the HIV, the lymphomes, the néoplasies or the autoimmunes / inflammatory diseases following the criteria of the HLH Society modified in 2004
group control
- Of more than 18 years old
- At the time of the diagnosis either of firstly viral infection (EBV, CMV, parvovirus B19, HSV), is of lymphome cunning(malignant) not - Hodgkinien or of epithelial métastasés cancers, or auto-immune disease (erythemic lupus and disease of Still of the adult only) without associated criteria corresponding to the diagnosis of LHS
- have agreed to benefit from a pregnancy test and from a screening sérologique by the infection by the HIV. These tests that must be negative. In case of positivity of the screening HIV, the patients will be directed to an adequate service.
- Have still received no preliminary treatment for this pathology
- Have agreed to participate in the study and to have signed the form of consent
group healthy control They will have to be unhurt of active infectious pathology, hématologique, auto-immune or neoplastic and have by receipt of immunosuppresseurs treatments during the last 2 years.
Exclusion Criteria:
Patients Hemophagocytic lymphohisticytosis group:
- Minor patients under age 18 or vulnerable (encircled women, private persons of freedom judicially or administratively, adults under guardianship, under guardianship and to express their consent)
- histories of established LHF or episode of LH during the childhood
- patients reached(affected) by infection by the HIV: either histories known for seropositivity and / or of disease, or because of the positivity of the test sérologique realized in the inclusion after consent of the patient.
- Have already benefited from a specific treatment of the LHS
group control
Patients under age 18 and not to belong in one group of vulnerable persons (encircled women, private persons of freedom judicially or administratively, adults under guardianship, under guardianship and to express their consent)
- Patients answering the criteria of diagnosis of LHS
- Patients having already had histories of LH
- Patients having already received the specific treatments of these diseases
- patients reached(affected) by infection by the HIV: either histories known for seropositivity and / or of disease, or because of the positivity of the test sérologique realized in the inclusion after consent of the patient.
group healthy control Patients under age 18 and not to belong in one group of vulnerable persons (encircled women, private persons of freedom judicially or administratively, adults under guardianship, under guardianship and to express their consent)
Sites / Locations
- Assistance Publique Hopitaux de Marseille
Arms of the Study
Arm 1
Arm 2
Arm 3
Other
Other
Other
patients Hemophagocytic lymphohisticytosis group
group control patient
healthy control group